The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChrysalis Inves Regulatory News (CHRY)

Share Price Information for Chrysalis Inves (CHRY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 77.10
Bid: 76.60
Ask: 77.10
Change: 1.00 (1.31%)
Spread: 0.50 (0.653%)
Open: 77.90
High: 79.90
Low: 75.70
Prev. Close: 76.10
CHRY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

18 Oct 2021 14:39

RNS Number : 4217P
Chrysalis Investments Limited
18 October 2021
 

The information contained in this announcement is restricted and is not for publication, release or distribution in the United States of America, any member state of the European Economic Area, Canada, Australia, Japan or the Republic of South Africa.

 

18 October 2021

Chrysalis Investments Limited (the "Company")

Director/PDMR shareholding

The Company wishes to announce in accordance with DTR 3.1 and Article 19 of The Market Abuse Regulation the following dealing in the Company's ordinary shares of no-par value by persons discharging managerial responsibility. The Company can also confirm that the employee benefit trust of the Company's Investment Adviser has participated in the Initial Issue in order to meet the deferred remuneration obligations of the Investment Adviser.

 

 

Details of the person discharging managerial responsibilities/person closely associated

Name

Samuel Cruttenden

 

Reason for the notification

 

Position/status

PCA (Son of Tim Cruttenden - Independent Director of the Board)

 

Initial Notification / Amendment

Initial Notification

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Chrysalis Investments Limited

LEI

213800F9SQ753JQHSW24

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument,

type of

instrument

Identification code

Ordinary shares of no par value

 

ISIN: GG00BGJYPP46

Nature of the transaction

Purchase

 

Price(s) and volume(s)

 

Price(s)

Volume(s)

236.97p

3,795

Aggregated information

- Aggregated volume

- Price

 

N/A (Single Transaction)

 

Date of the transaction

20 October 2021

 

Place of the transaction

LONDON STOCK EXCHANGE, (XLON)

 

Additional Information

 

 

This announcement is made in accordance with the requirements of the EU Market Abuse Regulation ("MAR") and the Company confirms that the PDMR's notification obligations under MAR have also been satisfied.

For further information, please contact:

 

Media:

Montfort Communications

Charlotte McMullen/ Toto Reissland- Burghart/ Miles McKechnie

 

 

 

 

+44 (0) 20 3770 7920

chrysalis@montfort.london

 

Jupiter Asset Management:

Magnus Spence

 

+44 (0) 20 3817 1325

Liberum:

Chris Clarke / Darren Vickers / Owen Matthews

 

+44 (0) 20 3100 2000

Numis:

Nathan Brown / Matt Goss

 

+44 (0) 20 7260 1000

Maitland Administration (Guernsey) Limited:

Elaine Smeja / Aimee Gontier

+44 (0) 1481 749364

 

 

A copy of this announcement will be available on the Company's website at http://chrysalisinvestments.co.uk. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

 

LEI: 213800F9SQ753JQHSW24

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFVVIDLTLIL
Date   Source Headline
21st Sep 20222:47 pmRNSHolding(s) in Company
9th Sep 202212:36 pmRNSResearch from QuotedData
2nd Sep 202211:51 amRNSHolding(s) in Company
23rd Aug 20222:10 pmRNSDirector/PDMR Shareholding
22nd Aug 20227:00 amRNSQuarterly NAV Announcement and Trading Update
22nd Jul 202210:49 amRNSHolding(s) in Company
12th Jul 20227:00 amRNSPortfolio Update
11th Jul 20221:17 pmRNSPortfolio Update
30th Jun 20227:00 amRNSInterim Results
7th Jun 20227:00 amRNSNew Independent Valuation Committee
30th May 20227:00 amRNSDirector/PDMR Shareholding
23rd May 20227:00 amRNSQuarterly Net Asset Value and Trading Update
13th May 202211:40 amRNSDirector/PDMR Shareholding
14th Apr 20227:00 amRNSInterim NAV Announcement
17th Mar 202211:34 amRNSHolding(s) in Company
21st Feb 20227:00 amRNSQuarterly NAV Announcement and Trading Update
18th Feb 20222:21 pmRNSPublication of a Supplementary Prospectus
18th Feb 20227:00 amRNSResult of AGM
10th Feb 20224:15 pmRNSDirector/PDMR Shareholding
4th Feb 20224:52 pmRNSCorrection to AGM Resolution No. 11
3rd Feb 20223:19 pmRNSDirector/PDMR Shareholding
1st Feb 20222:06 pmRNSPortfolio Update
1st Feb 20227:00 amRNSNotice of AGM
31st Jan 20224:19 pmRNSHolding(s) in Company
31st Jan 202210:59 amRNSHolding(s) in Company
26th Jan 20227:00 amRNSAnnual Financial Report
16th Dec 202111:24 amRNSHolding(s) in Company
13th Dec 20217:00 amRNSResults of Capital Raise
1st Dec 20217:01 amRNSPrimaryBid Offer
1st Dec 20217:00 amRNSProposed Placing
29th Nov 20217:01 amRNSUpdate on Performance Fee Arrangements
29th Nov 20217:00 amRNSNet Asset Value(s) and Trading Update
18th Oct 20212:39 pmRNSDirector/PDMR Shareholding
18th Oct 20212:36 pmRNSDirector/PDMR Shareholding
11th Oct 20217:00 amRNSDepositary Business Transfer
17th Sep 20211:12 pmRNSHolding(s) in Company
20th Aug 20217:00 amRNSQuarterly NAV Announcement
19th Aug 20217:00 amRNSPortfolio Update
17th Aug 202111:29 amRNSPortfolio Update
5th Aug 20214:33 pmRNSUK Government Engagement
29th Jul 20217:00 amRNSPortfolio Update
7th Jul 202111:58 amRNSPortfolio Update
6th Jul 20217:00 amRNSPortfolio Update
30th Jun 20217:00 amRNSInterim Results to 31 March 2021
29th Jun 20217:00 amRNSPortfolio Update
28th Jun 20217:00 amRNSPortfolio Update
25th Jun 20211:02 pmRNSHolding(s) in Company
24th Jun 20217:00 amRNSPortfolio Update
10th Jun 20212:17 pmRNSPortfolio Update
1st Jun 20212:38 pmRNSPortfolio Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.